A type 3 secretion system (T3SS) is a needle-like molecular device that certain bacteria use to inject proteins directly into the cells of a host organism. Think of it as a microscopic syringe: the bacterium builds a hollow needle that physically punctures a host cell’s membrane and pumps in proteins that hijack the cell’s normal functions. This injection system is one of the most important tools that disease-causing bacteria like Salmonella, Shigella, and Yersinia use to establish infections.
How the Needle Is Built
The T3SS is assembled from more than 20 different proteins, and the final structure has four main parts: a base, a needle, a tip, and a pore-forming component called the translocon.
The base sits in the bacterial cell wall, anchored by a set of ring-shaped protein structures that span both layers of the bacterium’s double membrane. Beneath these rings is an export apparatus (a set of five membrane proteins) and an enzyme that provides the energy to push proteins through the system. This base is essentially the engine room.
Extending outward from the base is the needle itself, a hollow cylindrical tube made of many copies of a single small protein stacked together. The needle projects from the bacterial surface into the surrounding environment. At the very tip of the needle sits a cap made of roughly five copies of another protein, arranged in a ring. This tip cap serves as a landing pad for the final piece of the apparatus: the translocon, which is a pair of proteins that can insert themselves into a host cell’s membrane to form a pore. Once that pore is in place, the bacterium has a continuous channel running from its own interior, through the needle, and into the host cell.
What Triggers the Injection
The T3SS doesn’t fire randomly. Secretion of harmful proteins is triggered specifically by physical contact with a host cell. Only needles that have engaged a target cell begin pumping effectors through, and the proteins are injected into the cell rather than released into the surrounding fluid. This precision matters because the bacterium carries a limited supply of these weapons and can’t afford to waste them.
Several triggering mechanisms have been proposed over the years, including changes in calcium concentration near the host cell surface or shifts in pH. Recent research points to the translocon pore itself as the sensor. When the pore-forming proteins insert into a host membrane, they undergo a shape change that sends a signal back down through the needle to the base, essentially telling the export machinery to start pumping. If the translocon doesn’t assemble properly, effector secretion never gets switched on.
What the Injected Proteins Do
The proteins pushed through the needle are called effectors, and they’re the real weapons. Once inside a host cell, effectors manipulate the cell’s own machinery in ways that benefit the bacterium. Different species inject different cocktails, but the targets tend to fall into a few major categories.
One of the most common targets is the cell’s internal skeleton, particularly the network of actin filaments that gives a cell its shape and allows it to move. Effectors can reorganize actin to force the host cell to engulf the bacterium (useful for Salmonella, which lives inside cells) or to disrupt the tight seals between cells lining the gut, opening gaps that let bacteria slip deeper into tissue.
Effectors also suppress the immune response. They interfere with key signaling pathways that cells use to raise an alarm when they detect a pathogen. By dialing down these inflammatory signals, the bacterium buys itself time to multiply before the immune system can mount an effective defense. Both the innate response (the body’s first-line, general-purpose defenses) and the adaptive response (the more targeted, slower response involving immune memory) can be blunted by T3SS effectors.
Which Bacteria Use It
The T3SS is found exclusively in gram-negative bacteria, the type with a double-layered outer membrane. Among human pathogens, the best-studied examples are Salmonella (food poisoning and typhoid fever), Shigella (bacterial dysentery), Yersinia (plague and severe gastrointestinal infections), Pseudomonas (lung infections, particularly dangerous in hospital settings), and certain strains of E. coli that cause severe diarrheal disease.
The system isn’t limited to animal pathogens. Plant-pathogenic bacteria use their own versions to attack crops, and nitrogen-fixing rhizobia use a related system to establish symbiotic relationships with plant roots. Across all of biology, T3SS has evolved into at least seven recognized families. Three of these (called Ysc, SPI-1, and SPI-2) are typically found in animal pathogens. Two others (Hrp1 and Hrp2) appear mainly in plant pathogens. Another family is common in plant-symbiotic bacteria, and one more shows up in bacteria that infect insects and single-celled organisms. Some bacteria, like Salmonella, carry two separate T3SS on different parts of their chromosome, using one to invade cells and the other to survive once inside.
Recent work has also found T3SS genes in non-pathogenic gut bacteria, suggesting the system isn’t purely a weapon. Some commensal bacteria in a healthy gut may use it to communicate with or modulate the immune system in beneficial ways.
Connection to the Bacterial Flagellum
The T3SS shares a clear evolutionary relationship with the bacterial flagellum, the spinning tail that many bacteria use to swim. The base of the flagellum contains its own protein export system (used to build the flagellar filament), and the core components of that export machinery are structurally similar to the T3SS. Both systems use a similar energy-providing enzyme to unfold proteins and thread them through a channel.
Which came first is still debated, but the homology is strong enough that some non-flagellated bacteria still carry remnants of the flagellar export genes and repurpose them for entirely different functions, like controlling surface-based gliding movement. This kind of evolutionary recycling underscores how versatile the basic T3SS architecture is.
T3SS as a Drug Target
Because the T3SS is essential for infection but not for bacterial survival in a test tube, it’s an attractive target for a new class of drugs called antivirulence agents. The idea is to disarm the bacterium rather than kill it outright, which could reduce the pressure that drives antibiotic resistance.
Two major classes of small molecules have shown the most promise in laboratory studies. One group, called salicylidene acylhydrazides, has been tested against a range of bacteria including Yersinia, Salmonella, Shigella, and Chlamydia. These compounds appear to interfere with multiple steps in the secretion process depending on the species. The other group, thiazolidinones, has shown activity against Yersinia and Salmonella and may work by blocking a ring-shaped protein in the base of the needle apparatus. Beyond these two, researchers have identified dozens of other candidate compounds from diverse chemical families, some targeting the needle protein itself, others blocking the energy-providing enzyme, and still others interfering with the regulatory genes that switch the system on. None have reached clinical use yet, but the breadth of potential targets within the T3SS makes it a rich area for drug development.